Bottom line
How much do PHLAX and HGHAX overlap?
51% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 50.0% of PHLAX's assets and 38.0% of HGHAX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings PHLAX and HGHAX have in common
| Holding | % of PHLAX | % of HGHAX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 17.35% | 12.03% | 12.03% |
| Merck & Company Inc MRK | 6.06% | 6.00% | 6.00% |
| Unitedhealth Group Inc UNH | 5.87% | 4.74% | 4.74% |
| Thermo Fisher Scientific Inc TMO | 4.56% | 1.58% | 1.58% |
| Vertex Pharmaceuticals Inc VRTX | 3.37% | 2.64% | 2.64% |
| Danaher Corp DHR | 3.28% | 2.57% | 2.57% |
| Intuitive Surgical Inc ISRG | 3.07% | 2.88% | 2.88% |
| Cvs Health Corp CVS | 2.52% | 2.84% | 2.52% |
| Stryker Corp SYK | 2.16% | 1.24% | 1.24% |
| Agilent Technologies Inc A | 1.73% | 1.54% | 1.54% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PHLAX
- Argenx Se — 3.55%
- Lonza Group Ag — 3.02%
- (PIPA070) PGIM Core Government Money Market Fund — 2.50%
- Insmed Inc — 2.28%
- Roivant Sciences Ltd — 2.21%
- Sionna Therapeutics Inc — 2.01%
- Beone Medicines Ltd — 1.82%
- Vaxcyte Inc — 1.77%
- Align Technology Inc — 1.75%
- Palvella Therapeutics Inc — 1.56%
- Apogee Therapeutics Inc — 1.42%
- Cabaletta Bio Inc — 1.35%
- Prudential Investment Portfolios 9 — 1.31%
- Newamsterdam Pharma Company Nv — 1.30%
- Dianthus Therapeutics Inc — 1.28%
Only in HGHAX
- Johnson & Johnson — 6.75%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Edwards Lifesciences Corp — 2.48%
- Cencora Inc — 2.46%
- Regeneron Pharmaceuticals Inc — 2.02%
- HCA Healthcare Inc — 1.88%
- Boston Scientific Corp — 1.88%
- Abbott Laboratories — 1.82%
- Amgen Inc — 1.39%
- Biogen Inc — 1.36%
- Gsk Plc — 1.17%
- Medtronic PLC — 1.12%
- Centene Corp — 1.10%
- Dexcom Inc — 1.01%
Asset mix
| Asset type | PHLAX | HGHAX |
|---|---|---|
| Stocks | 97.8% | 98.1% |
| Cash & short-term funds | 3.8% | 0.9% |
| Repurchase agreements | — | 0.4% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)
Country mix
| Country | PHLAX | HGHAX |
|---|---|---|
| US | 84.7% | 89.6% |
| NL | 5.4% | 1.5% |
| CH | 4.8% | 0.7% |
| GB | 1.1% | 2.4% |
| IE | — | 2.2% |
| BM | 2.2% | — |
| CA | 1.0% | 0.3% |
| IL | 1.0% | — |
Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PHLAX and HGHAX overlap?
What stocks do PHLAX and HGHAX have in common?
Should I own both PHLAX and HGHAX?
Which holds more stocks, PHLAX or HGHAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.